One, Etiology
To study the causes of spina bifida, it is necessary to understand the normal process of neural embryonic development. On the 16th day of human embryonic development, the ectoderm above the notochord thickens to form a neural plate, which then increases bilaterally to form neural folds and converge towards the midline, fusing to form the neural tube. The fusion of the neural tube first appears on the 22nd day, at the level of the third somite, which is the future brainstem formation area. The fusion starts from the optic vesicle and develops towards both the head and tail. The anterior neural tube closes between the 23rd and 26th day of embryonic development, and if it does not close completely, it can lead to craniorachischisis and anencephaly. The posterior neural tube closes between the 26th and 30th day of embryonic development, and if it does not close completely, it can lead to spina bifida.
Two, Pathogenesis
Spina bifida is a neural tube defect (NTD), and NTD is a polygenic genetic disease with an extremely complex pathogenesis, involving multiple aspects. Many factors can interfere with the process of onset, and according to animal experiments, clinical observations, and epidemiological studies, it is believed that NTD is the result of the combined effects of genetic factors and environmental factors (uterine environment):
1. Genetic Factors In the study of the pathogenesis of NTDs, it is difficult to distinguish between the effects of polygenic or multifactorial action and the complex effects of environmental factors, such as the common living environment in certain families. Therefore, in the pathogenesis, certain characteristics are usually attributed to the effects of genetic factors, such as changes in the incidence rates of NTDs among different regional and ethnic populations, high incidence rates of NTDs in consanguineous marriages, and high recurrence risks of NTDs within NTD families.
Family studies have shown that pregnant women with a family history of NTDs have a higher probability of giving birth to NTD infants than the general population. The research by Cater and Evans suggests that if either parent has a history of NTDs, the incidence rate of NTDs in their offspring is 3%, which is significantly higher than that of the general population. The risk of giving birth to an NTD infant is increased by 10% for mothers who have had two or more NTD pregnancies. Additionally, the incidence rate of NTDs in twins is higher than that of the general population, and the incidence rate of NTDs in monozygotic twins is higher than that in dizygotic twins. These research results all support the role of genetic factors in NTDs.
The research results on the genetics of NTDs cannot be explained by Mendelian genetic laws of single-gene mutations, but rather by the basis of multiple gene inheritance, that is, minor genes. There are no recessive or dominant differences between the minor genes, and their effects are cumulative. The occurrence of disease can be triggered when the cumulative effects and the effects of environmental factors reach a certain threshold. Therefore, the occurrence of NTDs is caused by polygenic inheritance, and the role of genetic factors in the occurrence of NTDs has not yet been determined.
2. Environmental Factors Environmental teratogens usually act on the mother in the early stages of pregnancy, typically within the first 3 months, leading to obstacles in the development of the neural tube and causing malformations. Common environmental factors associated with NTDs include deficiencies of folic acid and various vitamins during the early stages of pregnancy, deficiencies of zinc and other trace elements, severe pregnancy reactions, viral infections, the use of certain drugs, alcoholism, radiation exposure, and contact with certain chemical substances.
Research has focused on the relationship between the deficiency of folic acid and various vitamins (including vitamin A, B1, B2, C, D, E, niacin, etc.) during the early stages of pregnancy and the occurrence of neural tube defects (NTDs), especially the relationship between folic acid and NTDs, which has made breakthrough progress since the 1980s. It has now been confirmed that folic acid deficiency during the early stages of pregnancy is the main cause of NTDs. Various reasons such as insufficient intake, poor absorption, metabolic disorders, or the need for increased intake can lead to folic acid deficiency, causing obstacles in DNA synthesis and thus affecting cell division and proliferation. Folic acid is a water-soluble vitamin and an essential nutrient for the early neural development of the fetus. The early stages of pregnancy are the time when the embryo is differentiating and the placenta is forming, with intense cell growth and division. If the pregnant woman lacks folic acid, it will affect the normal development of the fetal nervous system, the雏形 of the neural tube, and later may lead to poor fusion of the skull or vertebral bones, resulting in NTDs and causing spontaneous abortion or stillbirth.
Maternal early pregnancy zinc deficiency is also an environmental factor that can cause NTD in the fetus. Other trace elements such as copper, calcium, selenium, etc., may also induce NTD, but their exact role is not yet clear. As for the cause of NTD induced by severe pregnancy reaction, it may be due to temporary dehydration caused by severe vomiting, resulting in a lack of trace elements (such as zinc) or vitamins (such as folic acid).
Virological studies have shown that maternal early pregnancy infection with cytomegalovirus or type A influenza virus can cause developmental disorders of the fetal central nervous system, and NTD may occur. Early pregnancy toxoplasmosis infection may also lead to NTD. Maternal early pregnancy abdominal or pelvic radiation exposure often affects the development of the fetal central nervous system, and some develop NTD.
Pregnant women with epilepsy taking antiepileptic drugs such as valproate, phenobarbital, and phenytoin sodium, and their offspring are prone to develop NTD. Taking oral contraceptives during the early pregnancy, taking certain antitumor drugs such as methotrexate, adenine (aminopurine), and mercaptopurine, as well as the large or continuous application of cortisone or prednisolone (prednisolone), can induce NTD. The mechanism of action may be related to the interference of folic acid metabolism.